Unassociated Document
United
States
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION
12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File No. 0-22710
Interpharm
Holdings, Inc.
(Exact
name of registrant as specified in its charter)
75
Adams
Avenue, Hauppauge, New York 11788 Tel.
631-952-0214
(Address,
including zip code, and telephone number, including
area
code, of registrant’s principal executive offices)
Common
Stock, par value $.01 per share; Series A Preferred Stock, par value $.01 per
share
(Title
of
each class of securities covered by this Form)
(Titles
of all other classes of securities for which a duty
to
file
reports under Section 13(a) or 15(d) remains)
Please
place an [x] in the box(es) to designate the appropriate rule
provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule
12g-4(a)(1)(i)
|
|
|
Rule
12h-3(b)(1)(i)
|
x
|
Rule
12g-4(a)(1)(ii)
|
|
|
Rule
12h-3(b)(1)(ii)
|
|
Rule
12g-4(a)(2)(i)
|
|
|
Rule
12h-3(b)(2)(i)
|
|
Rule
12g-4(a)(2)(ii)
|
|
|
Rule
12h-3(b)(2)(ii)
|
|
|
|
|
Rule
15d-6
|
|
Approximate
number of holders of record as of the certification or notice
date: 267
Pursuant
to the requirements of the Securities Exchange Act of 1934, Interpharm Holdings,
Inc. has caused this certification/notice to be signed on its behalf by the
undersigned duly authorized person.
|
Interpharm
Holdings,
Inc. |
|
|
Dated:
5/13/2008
|
By:
Peter Giallorenzo,
CFO
|